Gerresheimer Opens a Representative Office in India - Gerresheimer Steps Up Business Operations in Emerging Markets

The establishment of a representative office in Mumbai/India reflects the company's commitment to the strategy of profiting from the consistent growth in emerging markets.

Gerresheimer intends to advance its very promising pharmaceutical primary packaging and drug delivery systems business in the growth market of India. In addition to sales operations, the company is also stepping up its local customer services and technical services. 

"Our strategic objective is to achieve above average growth in the emerging markets. We currently generate around ten percent of our revenues in these dynamically growing markets and we aim to double this figure over the next three years. Opening our representative office in India is an important step towards achieving this objective," said Uwe Rohrhoff, CEO of Gerresheimer AG.

Alongside China, where Gerresheimer already has seven production facilities, the fast-growing Indian pharma market is continually gaining in significance. There is incessant growth of demand for medicines in India. One reason for this is the improvement of the Indian healthcare system, which gives people greater access to medications. International pharmaceutical groups are now also manufacturing more products in India for other regions. Leading market research institutes expect above average growth rates in emerging nation pharma markets over coming years. 

About Gerresheimer 

Gerresheimer is a leading manufacturer of high quality specialty glass and plastic products for the international pharmaceuticals and healthcare industries. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group has production operations at 40 sites in Europe, North and South America and Asia. It realizes sales of around one billion euros and has 9,500 employees. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.